封面
市場調查報告書
商品編碼
1912173

內毒素檢測市場:市場洞察、競爭格局與預測(2033 年)

Endotoxin Testing Market Insights, Competitive Landscape, and Market Forecast - 2033

出版日期: | 出版商: Fairfield Market Research | 英文 196 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球內毒素檢測市場正經歷顯著成長,這主要得益於更嚴格的監管標準、技術進步以及製藥、生物技術和醫療器材產業對產品安全性的日益重視。 2026 年,該市場規模為 15 億美元,預計到 2033 年將達到 29 億美元,預測期內複合年增長率 (CAGR) 將達到 10%。

市場概覽

內毒素(脂多醣)是存在於革蘭氏陰性菌外膜上的有害物質。注射劑、生物製品和醫療器材受到內毒素污染會導致嚴重的健康問題,包括發燒、感染性休克和發炎反應。 包括美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA) 以及其他藥品監管機構在內的全球監管機構,均要求對所有註射劑和生物製品進行嚴格的內毒素檢測。

市場正在經歷顯著的創新,超越傳統的檢測方法,採用自動化、高通量和高靈敏度的內毒素檢測技術。這種發展確保了更高的準確性、更快的檢測結果以及對嚴格安全標準的遵守,為製造商和研究實驗室提供了可靠的內毒素污染檢測和管理解決方案。

主要市場驅動因子

推動內毒素檢測市場成長的因素如下:

  • 1. 監管要求:全球監管機構強制要求對所有生物製品、注射劑和醫療器材進行全面的內毒素檢測,從而產生了對檢測解決方案的穩定需求。
  • 2.製藥和生物技術領域的成長:隨著疫苗、生物製品以及細胞和基因療法的不斷發展,精準的內毒素檢測對於確保患者安全至關重要。 3. 技術進步:自動化、高通量檢測方法的引入,例如顯色法、濁度法和凝膠法,提高了檢測的效率和可靠性。 4. 關注病人安全:人們對內毒素相關風險的認知不斷提高,促使企業實施嚴格的檢測方案和預防措施。 5. 新興市場擴張:亞太和拉丁美洲地區製藥和醫療器材製造的快速發展為市場參與者提供了巨大的成長機會。

商機

內毒素檢測市場為企業和檢測實驗室提供了許多商機:

  • 自動化和高通量檢測:自動化系統可減少人為誤差,提高檢測結果的重複性,並加快檢測週期。
  • 外包和客製化服務:專業的內毒素檢測服務供應商可提供經濟高效的解決方案,尤其適合中小型製造商。
  • 拓展新興市場:亞太和拉丁美洲地區醫療基礎設施和藥品生產的擴張為市場開闢了新的成長途徑。
  • 創新產品:開發低內毒素回收率 (LER) 產品以及用於先進生物製劑和治療性蛋白質的內毒素去除解決方案是關鍵的成長領域。

區域分析

  • 北美:北美市場佔主導地位,這得益於其眾多大型製藥和生物技術公司、嚴格的監管以及先進的實驗室基礎設施。
  • 歐洲:歐洲市場預計將保持穩定成長,這得益於其強有力的監管、完善的研究機構以及自動化內毒素檢測技術的日益普及。
  • 亞太地區:亞太地區預計將以最高的複合年增長率成長,這得益於其快速的工業化進程、不斷擴大的製藥生產以及不斷增長的醫療保健投資。
  • 拉丁美洲:不斷增長的藥品產量和國際品質標準的採用正在推動市場成長。
  • 中東和非洲:醫療保健基礎設施的不斷改進以及病人安全意識的日益增強正在促進市場發展。

主要公司

全球內毒素檢測市場競爭激烈,許多跨國公司和專業實驗室提供種類繁多的產品和服務。主要市場參與者包括:

  • 賽默飛世爾科技 (Thermo Fisher Scientific)
  • 默克集團 (Merck KGaA,旗下品牌為 MilliporeSigma)
  • 查爾斯河實驗室 (Charles River Laboratories)
  • 龍沙集團 (Lonza Group)
  • 生物梅里埃公司 (bioMerieux SA)
  • Toxin Technology, Inc.
  • Hycult Biotech
  • Associates of Cape Cod, Inc.
  • Sciex (丹納赫集團)
  • 富士軟片與光純藥美國公司 (FUJIFILM Wako Chemicals USA Corporation)
  • IDEXX Laboratories, Inc.
  • BioStress LLC
  • R&D Systems (Bio Techne Corporation)
  • CTS (Creative Bioarray/China)
  • Insight Genomics, Inc.

這些公司正致力於持續的產品創新、策略聯盟、併購和地理擴張,以鞏固其市場地位。

市場區隔

依檢測方法:

  • 凝膠法內毒素檢測
  • 顯色法內毒素檢測
  • 濁度法內毒素檢測

依類型:

  • 內毒素檢測產品
  • 鱟試劑
  • 支原體檢測與清除
  • PCR支原體檢測試劑盒
  • 支原體清除混合液
  • 客製化支原體偵測與清除服務
  • 配件
  • 設備
  • 內毒素清除產品
  • 低內毒素回收率 (LER) 產品
  • 脂多醣

按應用:

  • 醫療器材製造業
  • 藥品製造
  • 包裝製造
  • 原料生產

依地區劃分:

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

目錄

第一章 摘要整理

第二章:市場概覽

  • 市場定義與細分
  • 市場動態
    • 驅動因素
    • 限制因素
    • 市場機遇
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響衝突
  • PESTLE 分析
  • 監理分析
  • 價格趨勢分析
    • 當前價格及未來預測,2025-2033 年
    • 價格影響因素

第三章 全球內毒素檢測市場預測,2020-2033 年

  • 全球內毒素檢測市場預測,按檢測方法劃分,價值(十億美元),2020-2033 年
    • 凝膠法內毒素檢測
    • 顯色法內毒素檢測
    • 濁度法內毒素檢測
  • 內毒素檢測市場預測,按類型劃分,價值(十億美元),2020-2033 年
    • 內毒素檢測產品
    • 鱟試劑 (LAL) 檢測試劑
    • 支原體檢測與移除
    • PCR 支原體檢測試劑盒
    • 支原體去除混合液
    • 支原體客製化血漿檢測與移除服務
    • 配件
    • 儀器
    • 內毒素去除產品
    • 低內毒素回收率 (LER) 產品
  • 內毒素檢測市場按應用領域劃分的預測,價值(十億美元),2020-2033 年
    • 醫療器材製造
    • 製藥製造
    • 包裝製造
    • 原料生產
  • 全球內毒素檢測市場按地區劃分的預測,價值(十億美元),2020-2033 年
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第四章:北美內毒素檢測市場展望(2020-2033)

第五章:歐洲內毒素檢測市場展望(2020-2033)

第六章:亞太地區內毒素檢測市場展望(2020-2033)

第七章:拉丁美洲內毒素檢測市場展望(2020-2033)

第八章:中東與非洲內毒素檢測市場展望(2020-2033)

第9章 競爭情形

  • 企業對市場區隔熱圖
  • 企業市場佔有率分析,2025年
  • 競爭儀表板
  • 企業簡介
    • Thermo Fisher Scientific
    • Merck KGaA (MilliporeSigma)
    • Charles River Laboratories
    • Lonza Group
    • bioMerieux SA
    • Toxin Technology, Inc.
    • Hycult Biotech
    • Associates of Cape Cod, Inc.
    • Sciex (Danaher)
    • FUJIFILM Wako Chemicals USA Corporation

第十章附錄

簡介目錄

The global endotoxin testing market is experiencing remarkable growth, driven by rising regulatory standards, technological advancements, and increased emphasis on product safety across pharmaceutical, biotechnology, and medical device industries. The market, valued at USD 1.5 billion in 2026, is projected to reach USD 2.9 billion by 2033, registering a robust CAGR of 10% during the forecast period.

Market Overview

Endotoxins, or lipopolysaccharides, are toxic substances present in the outer membrane of Gram-negative bacteria. Their contamination in injectable drugs, biologics, and medical devices can lead to severe health complications, including fever, septic shock, and inflammatory responses. This has prompted regulatory agencies worldwide, such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and various pharmacopeial authorities, to mandate rigorous endotoxin testing for all injectable and biologic products.

The market has witnessed significant innovation, moving beyond traditional testing methods to incorporate automated, high-throughput, and highly sensitive endotoxin detection technologies. This evolution ensures higher accuracy, faster results, and compliance with stringent safety standards, providing manufacturers and research organizations with reliable solutions to detect and control endotoxin contamination.

Key Market Drivers

Several factors are fueling the expansion of the endotoxin testing market:

  • 1. Regulatory Mandates: Global regulatory authorities require thorough endotoxin testing for all biologics, injectables, and medical devices, creating steady demand for testing solutions.
  • 2. Pharmaceutical and Biotech Growth: The increasing development of vaccines, biologics, and cell and gene therapies necessitates precise endotoxin detection to ensure patient safety.
  • 3. Technological Advancements: Adoption of automated, high-throughput methods such as chromogenic, turbidimetric, and gel clot assays enhances testing efficiency and reliability.
  • 4. Focus on Patient Safety: Growing awareness of endotoxin-related risks drives companies to adopt stringent testing protocols and preventive measures.
  • 5. Emerging Market Expansion: Rapid pharmaceutical and medical device manufacturing in Asia-Pacific and Latin America provides significant growth opportunities for market participants.

Business Opportunities

The endotoxin testing market offers multiple opportunities for companies and laboratories:

  • Automation and High-Throughput Testing: Automated systems reduce human error, improve reproducibility, and accelerate testing cycles.
  • Outsourced and Custom Services: Specialized endotoxin testing service providers offer cost-effective solutions, particularly for small and medium-sized manufacturers.
  • Emerging Market Penetration: Increasing healthcare infrastructure and pharmaceutical production in Asia-Pacific and Latin America open new avenues for growth.
  • Innovative Products: Development of low endotoxin recovery (LER) products and endotoxin removal solutions for advanced biologics and therapeutic proteins represents a significant growth segment.

Regional Analysis

  • North America: North America dominates the market due to the presence of leading pharmaceutical and biotechnology companies, stringent regulations, and advanced laboratory infrastructure.
  • Europe: Steady growth in Europe is driven by strong regulatory oversight, established research institutions, and growing adoption of automated endotoxin testing technologies.
  • Asia Pacific: The Asia-Pacific region is expected to grow at the highest CAGR, fueled by rapid industrialization, expansion of pharmaceutical manufacturing, and increasing healthcare investments.
  • Latin America: Market growth is supported by rising pharmaceutical production and adoption of international quality standards.
  • Middle East & Africa: Gradual improvements in healthcare infrastructure and growing awareness of patient safety contribute to market development.

Key Players

The global endotoxin testing market is highly competitive, with numerous multinational corporations and specialized laboratories offering a wide range of products and services. Leading market participants include:

  • Thermo Fisher Scientific
  • Merck KGaA (MilliporeSigma)
  • Charles River Laboratories
  • Lonza Group
  • bioMerieux SA
  • Toxin Technology, Inc.
  • Hycult Biotech
  • Associates of Cape Cod, Inc.
  • Sciex (Danaher)
  • FUJIFILM Wako Chemicals USA Corporation
  • IDEXX Laboratories, Inc.
  • BioStress LLC
  • R&D Systems (Bio Techne Corporation)
  • CTS (Creative Bioarray / China)
  • Insight Genomics, Inc.

These companies focus on continuous product innovation, strategic partnerships, mergers, and regional expansions to strengthen their market presence.

Market Segmentation

By Testing Methods:

  • Gel Clot Endotoxin Test
  • Chromogenic Endotoxin Test
  • Turbidimetric Endotoxin Test

By Type:

  • Endotoxin Detection Products
  • LAL Test Reagents
  • Mycoplasma Detection & Removal
  • PCR Mycoplasma Detection Kit
  • Mycoplasma Elimination Cocktail
  • Mycoplasma Detection and Elimination Custom Services
  • Accessories
  • Instrumentation
  • Endotoxin Removal Products
  • Low Endotoxin Recovery (LER) Products
  • Lipopolysaccharides

By Application:

  • Medical Device Manufacturing
  • Pharmaceutical Manufacturing
  • Packaging Manufacture
  • Raw Materials Production

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Endotoxin Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Endotoxin Testing Market Outlook, 2020 - 2033

  • 3.1. Global Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 3.1.1. Gel Clot Endotoxin Test
    • 3.1.2. Chromogenic Endotoxin Test
    • 3.1.3. Turbidimetric Endotoxin Test
  • 3.2. Global Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 3.2.1. Endotoxin Detection Products
    • 3.2.2. LAL Test Reagents
    • 3.2.3. Mycoplasma Detection & Removal
    • 3.2.4. PCR Mycoplasma Detection Kit
    • 3.2.5. Mycoplasma Elimination Cocktail
    • 3.2.6. Mycoplasma Detection and Elimination Custom Services
    • 3.2.7. Accessories
    • 3.2.8. Instrumentation
    • 3.2.9. Endotoxin Removal Products
    • 3.2.10. Low Endotoxin Recovery (LER) Products
  • 3.3. Global Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.3.1. Medical device manufacturing
    • 3.3.2. Pharmaceutical manufacturing
    • 3.3.3. Packaging manufacture
    • 3.3.4. Raw materials production
  • 3.4. Global Endotoxin Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Endotoxin Testing Market Outlook, 2020 - 2033

  • 4.1. North America Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 4.1.1. Gel Clot Endotoxin Test
    • 4.1.2. Chromogenic Endotoxin Test
    • 4.1.3. Turbidimetric Endotoxin Test
  • 4.2. North America Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 4.2.1. Endotoxin Detection Products
    • 4.2.2. LAL Test Reagents
    • 4.2.3. Mycoplasma Detection & Removal
    • 4.2.4. PCR Mycoplasma Detection Kit
    • 4.2.5. Mycoplasma Elimination Cocktail
    • 4.2.6. Mycoplasma Detection and Elimination Custom Services
    • 4.2.7. Accessories
    • 4.2.8. Instrumentation
    • 4.2.9. Endotoxin Removal Products
    • 4.2.10. Low Endotoxin Recovery (LER) Products
  • 4.3. North America Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.3.1. Medical device manufacturing
    • 4.3.2. Pharmaceutical manufacturing
    • 4.3.3. Packaging manufacture
    • 4.3.4. Raw materials production
  • 4.4. North America Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 4.4.2. U.S. Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 4.4.3. U.S. Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 4.4.4. Canada Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 4.4.5. Canada Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 4.4.6. Canada Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Endotoxin Testing Market Outlook, 2020 - 2033

  • 5.1. Europe Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 5.1.1. Gel Clot Endotoxin Test
    • 5.1.2. Chromogenic Endotoxin Test
    • 5.1.3. Turbidimetric Endotoxin Test
  • 5.2. Europe Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 5.2.1. Endotoxin Detection Products
    • 5.2.2. LAL Test Reagents
    • 5.2.3. Mycoplasma Detection & Removal
    • 5.2.4. PCR Mycoplasma Detection Kit
    • 5.2.5. Mycoplasma Elimination Cocktail
    • 5.2.6. Mycoplasma Detection and Elimination Custom Services
    • 5.2.7. Accessories
    • 5.2.8. Instrumentation
    • 5.2.9. Endotoxin Removal Products
    • 5.2.10. Low Endotoxin Recovery (LER) Products
  • 5.3. Europe Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.3.1. Medical device manufacturing
    • 5.3.2. Pharmaceutical manufacturing
    • 5.3.3. Packaging manufacture
    • 5.3.4. Raw materials production
  • 5.4. Europe Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.2. Germany Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.3. Germany Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.4. Italy Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.5. Italy Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.6. Italy Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.7. France Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.8. France Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.9. France Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.10. U.K. Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.11. U.K. Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.12. U.K. Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.13. Spain Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.14. Spain Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.15. Spain Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.16. Russia Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.17. Russia Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.18. Russia Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 5.4.19. Rest of Europe Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 5.4.20. Rest of Europe Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 5.4.21. Rest of Europe Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Endotoxin Testing Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 6.1.1. Gel Clot Endotoxin Test
    • 6.1.2. Chromogenic Endotoxin Test
    • 6.1.3. Turbidimetric Endotoxin Test
  • 6.2. Asia Pacific Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 6.2.1. Endotoxin Detection Products
    • 6.2.2. LAL Test Reagents
    • 6.2.3. Mycoplasma Detection & Removal
    • 6.2.4. PCR Mycoplasma Detection Kit
    • 6.2.5. Mycoplasma Elimination Cocktail
    • 6.2.6. Mycoplasma Detection and Elimination Custom Services
    • 6.2.7. Accessories
    • 6.2.8. Instrumentation
    • 6.2.9. Endotoxin Removal Products
    • 6.2.10. Low Endotoxin Recovery (LER) Products
  • 6.3. Asia Pacific Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.3.1. Medical device manufacturing
    • 6.3.2. Pharmaceutical manufacturing
    • 6.3.3. Packaging manufacture
    • 6.3.4. Raw materials production
  • 6.4. Asia Pacific Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.2. China Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.3. China Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.4. Japan Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.5. Japan Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.6. Japan Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.7. South Korea Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.8. South Korea Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.9. South Korea Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.10. India Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.11. India Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.12. India Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.13. Southeast Asia Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.14. Southeast Asia Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.15. Southeast Asia Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 6.4.16. Rest of SAO Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 6.4.17. Rest of SAO Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 6.4.18. Rest of SAO Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Endotoxin Testing Market Outlook, 2020 - 2033

  • 7.1. Latin America Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 7.1.1. Gel Clot Endotoxin Test
    • 7.1.2. Chromogenic Endotoxin Test
    • 7.1.3. Turbidimetric Endotoxin Test
  • 7.2. Latin America Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 7.2.1. Endotoxin Detection Products
    • 7.2.2. LAL Test Reagents
    • 7.2.3. Mycoplasma Detection & Removal
    • 7.2.4. PCR Mycoplasma Detection Kit
    • 7.2.5. Mycoplasma Elimination Cocktail
    • 7.2.6. Mycoplasma Detection and Elimination Custom Services
    • 7.2.7. Accessories
    • 7.2.8. Instrumentation
    • 7.2.9. Endotoxin Removal Products
    • 7.2.10. Low Endotoxin Recovery (LER) Products
  • 7.3. Latin America Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.3.1. Medical device manufacturing
    • 7.3.2. Pharmaceutical manufacturing
    • 7.3.3. Packaging manufacture
    • 7.3.4. Raw materials production
  • 7.4. Latin America Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.2. Brazil Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.3. Brazil Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 7.4.4. Mexico Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.5. Mexico Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.6. Mexico Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 7.4.7. Argentina Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.8. Argentina Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.9. Argentina Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 7.4.10. Rest of LATAM Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 7.4.11. Rest of LATAM Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 7.4.12. Rest of LATAM Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Endotoxin Testing Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Endotoxin Testing Market Outlook, by Testing methods, Value (US$ Bn), 2020-2033
    • 8.1.1. Gel Clot Endotoxin Test
    • 8.1.2. Chromogenic Endotoxin Test
    • 8.1.3. Turbidimetric Endotoxin Test
  • 8.2. Middle East & Africa Endotoxin Testing Market Outlook, by the type, Value (US$ Bn), 2020-2033
    • 8.2.1. Endotoxin Detection Products
    • 8.2.2. LAL Test Reagents
    • 8.2.3. Mycoplasma Detection & Removal
    • 8.2.4. PCR Mycoplasma Detection Kit
    • 8.2.5. Mycoplasma Elimination Cocktail
    • 8.2.6. Mycoplasma Detection and Elimination Custom Services
    • 8.2.7. Accessories
    • 8.2.8. Instrumentation
    • 8.2.9. Endotoxin Removal Products
    • 8.2.10. Low Endotoxin Recovery (LER) Products
  • 8.3. Middle East & Africa Endotoxin Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.3.1. Medical device manufacturing
    • 8.3.2. Pharmaceutical manufacturing
    • 8.3.3. Packaging manufacture
    • 8.3.4. Raw materials production
  • 8.4. Middle East & Africa Endotoxin Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.2. GCC Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.3. GCC Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.4. South Africa Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.5. South Africa Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.6. South Africa Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.7. Egypt Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.8. Egypt Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.9. Egypt Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.10. Nigeria Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.11. Nigeria Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.12. Nigeria Endotoxin Testing Market Outlook, by Application, 2020-2033
    • 8.4.13. Rest of Middle East Endotoxin Testing Market Outlook, by Testing methods, 2020-2033
    • 8.4.14. Rest of Middle East Endotoxin Testing Market Outlook, by the type, 2020-2033
    • 8.4.15. Rest of Middle East Endotoxin Testing Market Outlook, by Application, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Merck KGaA (MilliporeSigma)
    • 9.4.3. Charles River Laboratories
    • 9.4.4. Lonza Group
    • 9.4.5. bioMerieux SA
    • 9.4.6. Toxin Technology, Inc.
    • 9.4.7. Hycult Biotech
    • 9.4.8. Associates of Cape Cod, Inc.
    • 9.4.9. Sciex (Danaher)
    • 9.4.10. FUJIFILM Wako Chemicals USA Corporation

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations